MEDICENNA THERAPEUTICS CORP (MDNA)

CA58490H1073 - Common Stock

0.157  -0.02 (-13.16%)

After market: 0.1565 0 (-0.32%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-6-30)
2023
(2023-3-31)
2022
(2022-3-31)
2021
(2021-3-31)
2020
(2020-3-31)
Revenue
0.000.000.000.000.00
Operating Expenses
16.43M16.30M22.47M17.40M8.24M
Research and Development
9.71M9.30M16.47M10.87M6.82M
Selling, General, and Administrative Expenses
6.72M6.99M7.72M6.49M2.49M
Operating Income
-16.43M-16.30M-22.47M-17.40M-8.24M
Interest Income/Expense
7.68M6.25M-104.00K110.00K-30.00K
Other Income/Expense
N/AN/A104.00KN/AN/A
Non Recurring Items
N/AN/AN/AN/AN/A
Income Before Taxes
-8.76M-10.05M-22.58M-17.29M-8.28M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-8.76M-10.05M-22.58M-17.29M-8.28M
EBITDA
-16.43M-16.30M-22.43M-17.36M-8.23M
 
Per Share Data
EPS Diluted Total Ops
-0.13-0.16-0.42-0.35-0.26
Non GAAP EPS
-0.16-0.19-0.42-0.35-0.26
 
Statistics

All data in CAD

Charts